Advertisement
Screener

REVVITY, INC (RVTY) Proceeds from (Repayments of) Other Debt

2.3 / 5 stars · 54/120 Roast Me

REVVITY, INC Proceeds from (Repayments of) Other Debt

REVVITY, INC (RVTY) reported Proceeds from (Repayments of) Other Debt of $0 for the 6-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromRepaymentsOfOtherDebt · last filed 2026-08-11

  • REVVITY, INC proceeds from (repayments of) other debt for the quarter ending 2026-07-05 was $0.00.
  • REVVITY, INC proceeds from (repayments of) other debt for the quarter ending 2026-04-05 was $0.00.
  • REVVITY, INC proceeds from (repayments of) other debt for the quarter ending 2025-12-28 was -$363.00K.
  • REVVITY, INC proceeds from (repayments of) other debt for the quarter ending 2025-09-28 was -$55.00K, a 112.82% decline year-over-year.
  • REVVITY, INC proceeds from (repayments of) other debt for fiscal 2025 was -$521.00K.
  • REVVITY, INC proceeds from (repayments of) other debt for fiscal 2024 was -$11.59M, a 283.35% decline from fiscal 2023.
  • REVVITY, INC proceeds from (repayments of) other debt for fiscal 2023 was $6.32M.
  • REVVITY, INC proceeds from (repayments of) other debt for fiscal 2023 was -$1.29M.
Period endProceeds from (Repayments of) Other Debt 3 monthProceeds from (Repayments of) Other Debt 6 monthProceeds from (Repayments of) Other Debt 6 month as first filedProceeds from (Repayments of) Other Debt 9 monthProceeds from (Repayments of) Other Debt 9 month as first filedProceeds from (Repayments of) Other Debt 12 month
2026-07-05$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$0.00
10-Q · filed 2026-08-11
-$363.00K
derived: sum of 3 quarters · filed 2026-08-11
-$418.00K
derived: sum of 4 quarters · filed 2026-08-11
2026-04-05$0.00
10-Q · filed 2026-05-12
-$363.00K
derived: sum of 2 quarters · filed 2026-05-12
-$418.00K
derived: sum of 3 quarters · filed 2026-05-12
-$471.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-12-28-$363.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$418.00K
derived: sum of 2 quarters · filed 2026-02-24
-$471.00K
derived: sum of 3 quarters · filed 2026-08-11
-$521.00K
10-K · filed 2026-02-24
2025-09-28-$55.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$108.00K
derived: sum of 2 quarters · filed 2026-08-11
-$158.00K
10-Q · filed 2025-11-04
-$980.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-06-29-$53.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$103.00K
10-Q · filed 2026-08-11
-$925.00K
derived: sum of 3 quarters · filed 2026-08-11
-$496.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-03-30-$50.00K
10-Q · filed 2026-05-12
-$872.00K
derived: sum of 2 quarters · filed 2026-05-12
-$443.00K
derived: sum of 3 quarters · filed 2026-05-12
-$832.00K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-29-$822.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$393.00K
derived: sum of 2 quarters · filed 2026-02-24
-$782.00K
derived: sum of 3 quarters · filed 2026-02-24
-$11.59M
10-K · filed 2026-02-24
2024-09-29$429.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$40.00K
derived: sum of 2 quarters · filed 2025-11-04
-$10.77M
10-Q · filed 2025-11-04
-$11.67M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$389.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
-$11.20M
10-Q · filed 2025-08-05
-$12.10M
derived: sum of 3 quarters · filed 2026-02-24
-$12.11M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$10.81M
10-Q · filed 2025-05-06
-$11.71M
derived: sum of 2 quarters · filed 2026-02-24
-$11.72M
derived: sum of 3 quarters · filed 2026-02-24
-$12.36M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$895.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$908.00K
derived: sum of 2 quarters · filed 2026-02-24
-$1.54M
derived: sum of 3 quarters · filed 2026-02-24
$6.32M
10-K · filed 2026-02-24
2023-10-01-$13.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$649.00K
derived: sum of 2 quarters · filed 2024-11-06
$7.22M
10-Q · filed 2024-11-06
$6.41M
derived: sum of 4 quarters · filed 2025-02-25
2023-07-02-$636.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$7.23M
10-Q · filed 2024-08-06
$6.42M
derived: sum of 3 quarters · filed 2025-02-25
$6.76M
derived: sum of 4 quarters · filed 2025-02-25
2023-04-02$7.87M
10-Q · filed 2024-05-07
$7.06M
derived: sum of 2 quarters · filed 2025-02-25
$7.40M
derived: sum of 3 quarters · filed 2025-02-25
$7.64M
derived: sum of 4 quarters · filed 2025-02-25
2023-01-01-$810.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$467.00K
derived: sum of 2 quarters · filed 2025-02-25
-$228.00K
derived: sum of 3 quarters · filed 2025-02-25
-$1.29M
10-K · filed 2025-02-25
2022-10-02$343.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$582.00K
derived: sum of 2 quarters · filed 2023-11-07
-$482.00K
10-Q · filed 2023-11-07
-$487.00K
10-Q · filed 2022-11-14
-$1.42M
derived: sum of 4 quarters · filed 2024-02-27
2022-07-03$239.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$825.00K
10-Q · filed 2023-08-09
-$830.00K
10-Q · filed 2022-08-09
-$1.76M
derived: sum of 3 quarters · filed 2024-02-27
-$2.67M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-03-$1.06M
10-Q · filed 2023-05-12
-$2.00M
derived: sum of 2 quarters · filed 2024-02-27
-$2.91M
derived: sum of 3 quarters · filed 2024-02-27
-$4.93M
derived: sum of 4 quarters · filed 2024-02-27
2022-01-02-$939.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
-$1.84M
derived: sum of 2 quarters · filed 2024-02-27
-$3.87M
derived: sum of 3 quarters · filed 2024-02-27
-$13.67M
10-K · filed 2024-02-27
2021-10-03-$905.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$2.93M
derived: sum of 2 quarters · filed 2022-11-14
-$12.73M
10-Q · filed 2022-11-14
-$9.10M
derived: sum of 4 quarters · filed 2023-03-01
2021-07-04-$2.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$11.83M
10-Q · filed 2022-08-09
-$8.20M
derived: sum of 3 quarters · filed 2023-03-01
-$10.28M
derived: sum of 4 quarters · filed 2023-03-01
2021-04-04-$9.80M
10-Q · filed 2022-05-10
-$6.17M
derived: sum of 2 quarters · filed 2023-03-01
-$8.26M
derived: sum of 3 quarters · filed 2023-03-01
-$10.01M
derived: sum of 4 quarters · filed 2023-03-01
2021-01-03$3.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$1.54M
derived: sum of 2 quarters · filed 2023-03-01
-$211.00K
derived: sum of 3 quarters · filed 2023-03-01
-$4.49M
10-K · filed 2023-03-01
2020-10-04-$2.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$3.84M
derived: sum of 2 quarters · filed 2021-11-09
-$8.12M
10-Q · filed 2021-11-09
-$11.93M
derived: sum of 4 quarters · filed 2022-03-03
2020-07-05-$1.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
-$6.04M
10-Q · filed 2021-08-10
-$9.85M
derived: sum of 3 quarters · filed 2022-03-03
-$11.21M
derived: sum of 4 quarters · filed 2022-03-03
2020-04-05-$4.28M
10-Q · filed 2021-05-11
-$8.09M
derived: sum of 2 quarters · filed 2022-03-03
-$9.45M
derived: sum of 3 quarters · filed 2022-03-03
-$15.78M
derived: sum of 4 quarters · filed 2022-03-03
2019-12-29-$3.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
-$5.17M
derived: sum of 2 quarters · filed 2022-03-03
-$11.50M
derived: sum of 3 quarters · filed 2022-03-03
-$14.97M
10-K · filed 2022-03-03
2019-09-29-$1.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
-$7.69M
derived: sum of 2 quarters · filed 2020-11-10
-$11.17M
10-Q · filed 2020-11-10
2019-06-30-$6.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
-$9.81M
10-Q · filed 2020-08-11
2019-03-31-$3.48M
10-Q · filed 2020-05-12
2018-12-30-$28.38M
10-K · filed 2021-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16